Lim Bryant David

Track

Insider profile

Performance

Overall performance
1.9
Performance over holding periods
1.9
30 days 90 days 120 days
Average return 17% 8.2% 15.1%
Success rate 64% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Lim Bryant David's trades of Prelude Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
113.65
Quantity 74,796 +14.9%
Value US$286,367
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-20 2024-12-19
B Purchase
95,087 +45.1%
323.40
US$977,940 		95,087 +45.1% 323.40 US$977,940
2023-05-25 2023-05-24
B Purchase
74,796 +14.9%
113.65
US$286,367 		74,796 +14.9% 113.65 US$286,367
2021-03-29 2021-03-25
S Sale
95,346 -17.6%
258.65
US$3,142,415 		95,346 -17.6% 258.65 US$3,142,415
2021-01-12 2021-01-12
S Sale
1,711 -4.3%
4.21
US$7,202 		1,711 -4.3% 4.21 US$7,202
2021-01-11 2021-01-05
S Sale
1,465 -3.6%
3.91
US$5,722 		1,465 -3.6% 3.91 US$5,722
2020-01-10 2020-01-07
S Sale
1,603 -7.0%
1.78
US$2,854 		1,603 -7.0% 1.78 US$2,854